Cargando…
Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
No study has yet investigated if a severe SARS-CoV-2 infection represents a marker of an undiagnosed cancer. This population-based study, using the SNDS database, identified from 02/15/2020 to 08/31/2021, 41,302 individuals hospitalized in intensive care unit due to SARS-CoV-2 (ICU-gr) and 713,670 c...
Autores principales: | Dugerdil, Adeline, Semenzato, Laura, Weill, Alain, Zureik, Mahmoud, Flahault, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227779/ https://www.ncbi.nlm.nih.gov/pubmed/37253848 http://dx.doi.org/10.1038/s41598-023-36013-7 |
Ejemplares similares
-
L'infection sévère par SARS-CoV-2 comme marqueur d'un cancer non diagnostiqué - une étude populationnelle - France
por: Dugerdil, A., et al.
Publicado: (2023) -
Update on rapid diagnostic testing for SARS-CoV-2
por: Dugerdil, Adeline, et al.
Publicado: (2022) -
Infodemics in an Era of Pandemics
por: Emery, Nina, et al.
Publicado: (2022) -
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
por: Botton, Jérémie, et al.
Publicado: (2022) -
Rethinking International University Ranking Systems in the Context of Academic Public Health
por: Dugerdil, Adeline, et al.
Publicado: (2022)